GUANOSINE 3':5'-CYCLIC MONOPHOSPHATE SOD

TargetMol
Product Code: TAR-T5065
Supplier: TargetMol
CodeSizePrice
TAR-T5065-5mg5mg£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T5065-1mL1 mL * 10 mM (in DMSO)£119.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T5065-10mg10mg£134.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T5065-25mg25mg£177.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T5065-50mg50mg£229.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T5065-100mg100mg£306.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T5065-500mg500mg£630.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
GUANOSINE 3':5'-CYCLIC MONOPHOSPHATE, also known as cGMP, is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin. cGMP activates protein kinase G (PKG) and modulates ion channel conductance, with signaling affecting diverse processes including smooth muscle relaxation and proliferation, phototransduction, and energy homeostasis.
CAS:
40732-48-7
Formula:
C10H11N5NaO7P
Molecular Weight:
367.19
Pathway:
Tyrosine Kinase/Adaptors
Purity:
0.9953
SMILES:
[Na+].Nc1nc2n(cnc2c(=O)[nH]1)C1OC2COP([O-])(=O)OC2C1O
Target:
PKA

References

Hamad AM, et al. Guanylyl cyclases, nitric oxide, natriuretic peptides, and airway smooth muscle function. Am J Physiol Lung Cell Mol Physiol. 2003 Nov;285(5):L973-83. Rehim WM, et al. Antioxidant capacity in Fasciola hepatica patients before and after treatment with triclabendazole alone or in combination with ascorbic acid (vitamin C) and tocofersolan (vitamin E). Arzneimittelforschung. 2003;53(3):214-20. Roongpraiwan R , Suthutvoravut U , Feungpean B , et al. Effect of oral vitamin E supplementation in children with cholestasis.[J]. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2002, 85 Suppl 4:S1199.